How to Read a Certificate of Analysis

A certificate of analysis, or COA, is a lot-specific quality record that reports what a testing laboratory measured on one particular batch. It is not a marketing sheet and not a permanent property of the compound; it describes the material in front of you at the time it was tested. Reading one well means knowing which fields to expect, what each means, and where the common errors and ambiguities hide.

What a COA is for

The document exists to link a physical lot to a set of measured attributes so that a receiving laboratory can decide whether the material matches what was ordered. Every figure on it is a measurement with a method and a date behind it. That framing matters because it sets the reader’s job: not to trust the numbers because they are printed, but to check that the identity fields agree with the compound ordered and that the quality fields were produced by methods appropriate to them.

The example fields discussed below are illustrative of what a peptide COA typically carries. They should be read as the shape of the document rather than as a specific real lot; the values on a genuine certificate belong to the batch it was issued for.

The fields a peptide COA should carry

Field	What it reports	How to read it
Product name and code	The material the lot claims to be	Match against your order and the identity fields below, not on its own
CAS number	Registry identity of the substance	Confirm it is the exact number for the compound, including complex versus free-peptide forms
Lot or batch number	The unique handle for this production run	Record it; every other figure is scoped to this lot
Appearance	Physical description of the solid	Should match expectation, for example a white or coloured lyophilized powder
Purity (HPLC)	Percent by peak area from chromatography	Note the method and that it is an area percent, not an absolute assay
Identity (MS)	Mass-spectrometry confirmation	Observed mass should agree with the expected value for the sequence
Water or solvent content	Residual moisture or solvents	Relevant to net peptide content and storage
Counterion or salt content	Acetate or other counterion level	Explains why net peptide mass differs from gross powder mass
Test date and analyst	When and by whom the lot was tested	Anchors the record in time and to a responsible party

Identity fields come first

Before any quality number matters, the identity fields have to agree. The product name is the least reliable entry because names travel loosely, so the CAS number and any structural identifiers are the real check. For a compound supplied as a salt, confirm the counterion, since a net-peptide-content figure can differ from the gross powder mass by the mass of the associated acetate or other counterion. A certificate that omits identity fields, or lists a name without a registry number, is incomplete rather than merely brief.

Purity and identity are two different questions

Purity by HPLC answers how much of what is in the vial is the target species, expressed as a percentage of chromatographic peak area. Mass-spectrometry identity answers whether that main species is the right molecule. A material can be highly pure and still be the wrong compound, or the right compound at lower purity, which is why both fields belong on a complete certificate. The companion note on HPLC purity and mass-spec identity covers how each measurement is produced and read.

Treating certificate data as a sample, not a promise

One framing point underlies everything else on the document. A certificate reports a measurement made on a specific lot at a specific time; it is not a standing property of the compound and not a guarantee that a future lot will read identically. This is why example certificate figures, including the kind of purity values that appear in a catalogue, should be read as illustrations of the fields the document carries rather than as a fixed grade attached to the material forever. When a real lot arrives, its own certificate is the record that governs, and the sensible practice is to file that certificate against the lot number so the two never drift apart.

The same caution applies to any certificate presented without the provenance fields that tie it to a physical batch. A polished-looking document with no lot number, no test date, and no responsible analyst is a template, and a template describes no particular material. Reading a certificate critically means asking, at every field, whether the entry is a measurement of the thing in your hand or a generic placeholder, and treating the two very differently.

Where COA errors and ambiguities hide

Several recurring problems are worth watching for. A purity figure with no stated method is hard to interpret, since area percent from one gradient is not directly comparable to another. A missing lot number detaches every measurement from the physical batch. A CAS number that matches a related but different form, for instance a complex versus its free peptide, is a subtle identity error that a quick glance misses. And any certificate presented without a test date or a batch reference should be treated as a template rather than a record of a real lot.

A practical reading pass, then, runs identity first, quality second, provenance throughout: confirm the CAS number and structural fields, read purity and identity as separate questions with methods attached, and make sure a lot number and test date tie the whole document to a physical batch. Example certificates for catalogue materials can be reviewed under lab results, the reasoning behind research-use framing is covered in the FAQ, and related quality-control notes sit in the lab standards archive.

Common questions

What is a certificate of analysis?

A lot-specific quality record reporting what a testing laboratory measured on one particular batch, including identity and purity fields. It describes the material as tested on a given date, not a permanent property of the compound.

Which COA field is most important to check first?

The identity fields, especially the CAS number and any structural identifiers. The product name travels loosely, so it should be matched against the registry number rather than trusted on its own.

Why can net peptide content differ from the powder weight?

Because a peptide is often supplied as a salt. The counterion, such as acetate, and residual water add mass to the powder, so the net peptide content is lower than the gross weight in the vial.

References

HPLC Purity and Mass-Spec Identity Explained

On a peptide certificate of analysis, HPLC purity and mass-spectrometry identity usually sit next to each other, and they are easy to blur into a single impression of quality. They are not the same measurement. One asks how much of the material is a single species; the other asks whether that species is the intended molecule. Reading a certificate well depends on keeping the two questions apart.

What HPLC purity measures

High-performance liquid chromatography separates the components of a sample as they pass through a column at different rates, producing a trace of detector signal over time. Each distinct component appears as a peak. For a peptide, purity is typically reported as the area of the main peak expressed as a percentage of the total peak area in the run. A figure such as an example 99 percent by HPLC means that, under that method, the target peak accounted for about that share of the detected material.

Two cautions follow from how the number is produced. First, it is an area percent under a specific gradient, column, and detection wavelength, so a purity figure is only fully interpretable alongside its method. Second, it reports relative abundance of what the detector saw, which is why a purity result should always be read with its method note rather than as a standalone grade.

Why the method note matters

Reverse-phase HPLC is the common format for peptides, separating species largely by hydrophobicity. A shallow gradient can resolve closely related impurities that a steep one would hide under the main peak, so two certificates reporting the same percentage are not necessarily reporting the same thing. When a purity figure appears with no method at all, it is difficult to compare against anything, which is one of the recurring gaps flagged in the companion note on how to read a certificate of analysis.

What mass-spec identity measures

Mass spectrometry ionises the molecules in a sample and measures their mass-to-charge ratio, yielding an observed mass for the main species. For a peptide of known sequence, the expected mass can be calculated from the residues, and identity confirmation is the agreement between the observed and expected values within the instrument’s tolerance. Where a compound has a verified molecular formula and mass, such as a documented reference peptide, the calculated value gives the target the observed spectrum is checked against.

The key point is that mass spectrometry addresses identity, not abundance. It tells you the main component has the right mass to be the intended molecule; it is not, by itself, a statement about how much impurity accompanies it. That is the HPLC question.

Why a certificate needs both

Question	Method	What a good result shows	What it does not show
How much is one species?	HPLC purity	Main peak dominates total peak area	Whether that species is the right molecule
Is it the right molecule?	Mass-spec identity	Observed mass matches expected	How much impurity is present

The table makes the complementarity concrete. A material can be highly pure yet the wrong compound, if a single incorrect species dominates the trace. It can be the correct compound yet carry more impurity than intended, if the right mass is confirmed but the main peak is smaller than expected. Only the two results together support a defensible conclusion that a lot is both the intended molecule and acceptably pure. This is why a complete certificate reports purity and identity as separate entries with their own methods, rather than collapsing them into one grade.

Reading the two together

In practice, confirm identity first: does the observed mass match the expected value for the sequence ordered? Then read purity as a bounded, method-specific figure: what share of the detected material is that confirmed species, and under what chromatographic conditions? Taken in that order, the two measurements answer the whole question a receiving laboratory actually has, which is whether the vial contains enough of the right thing to use as a reference material.

Common ways the two get misread

Several habitual misreadings are worth naming. The first is treating a high purity percentage as proof of identity; it is not, because a single dominant impurity can produce an impressive area percent for the wrong molecule. The second is treating a confirmed mass as proof of purity; a correct mass on the main peak says nothing about how much minor material rides alongside it. The third, subtler than the first two, is comparing purity figures from different methods as though they were interchangeable. Because reverse-phase HPLC purity depends on the gradient, column, and detection settings, two certificates can both read the same percentage while having resolved impurities to very different degrees. Without the method note, the comparison is not meaningful.

A fourth misreading concerns the detector itself. A purity figure reflects what the detector responded to at the chosen wavelength, so a species that absorbs weakly there can be under-represented in the trace. This is not a reason to distrust HPLC, which remains the standard purity tool for peptides, but a reason to read its output as a method-bound measurement rather than an absolute census of everything in the vial. Holding all four cautions in view turns a pair of printed numbers into the two-part evidence they are actually meant to be.

Example test data for catalogue materials can be reviewed under lab results, the identity record for a documented reference peptide such as BPC-157 shows the kind of verified mass an MS result is checked against, and further quality-control notes sit in the lab standards archive.

Common questions

What does an HPLC purity percentage actually mean?

It is the area of the main peak as a percentage of total peak area under a specific chromatographic method. It reports how much of the detected material is one species, not whether that species is the correct molecule.

How is mass-spec identity different from purity?

Mass spectrometry confirms the main species has the expected mass for the intended molecule, answering identity. It does not measure how much impurity is present, which is what the HPLC purity figure reports.

Why does a certificate report both purity and identity?

Because they answer different questions. A material can be pure but the wrong compound, or the right compound at lower purity. Only both results together confirm a lot is the intended molecule and acceptably pure.

References

Cold-Chain Handling for Lyophilized Peptides

Lyophilized peptides are supplied as freeze-dried solids because that form is more stable than a solution, but stability is a function of handling, not a permanent guarantee. Cold-chain handling is the set of practices that keeps a research material in the condition its documentation assumes, from arrival through storage. This note covers the general principles at the level a laboratory records them, without preparation amounts, concentrations, schedules, or routes, which are outside its scope.

Why the lyophilized form is used

Freeze-drying removes most of the water from a peptide preparation, leaving a dry solid. Because many of the degradation pathways that affect peptides depend on water, a low-moisture solid slows those processes considerably compared with a solution held at the same temperature. That is the reason reference peptides are shipped and stored as powders. The practical consequence is that the two things a lyophilized peptide most needs protection from are the reintroduction of moisture and elevated temperature, with light exposure a third factor for sensitive sequences.

Core storage conditions

The conditions below are the general handling parameters commonly documented for lyophilized research peptides. Specific materials carry their own documented storage note; for example, a verified reference peptide in the catalogue is recorded for storage at -20 degrees Celsius, protected from light.

Factor	General handling practice	Why it matters
Temperature	Store the sealed powder cold, commonly at -20 °C for longer holding	Lower temperature slows chemical and physical degradation
Moisture	Keep sealed and desiccated; allow to reach room temperature before opening	Condensation onto a cold powder reintroduces the water freeze-drying removed
Light	Protect from light, particularly for sequences with light-sensitive residues	Photodegradation can alter sensitive residues over time
Air and headspace	Minimise exposure; reseal promptly	Oxygen and humidity in air drive oxidation and moisture uptake

The warm-before-opening habit

One handling detail deserves emphasis because it is easy to skip. A vial taken straight from a freezer and opened in ambient air invites condensation onto the cold solid, undoing part of the reason the material was lyophilized in the first place. Allowing a sealed vial to equilibrate to room temperature before it is opened is a small step that protects the dry state. It is the kind of practice that belongs in a written handling procedure rather than in memory.

Transit and the cold chain

The cold chain is the unbroken sequence of controlled conditions from the point a material leaves storage to the point it is used. For research peptides the transit segment is where control is hardest to maintain, since packages move through environments no laboratory controls. Insulated packaging and coolant are the usual means of holding temperature in transit, and the receiving laboratory’s role is to inspect and record the condition of a shipment on arrival: whether coolant was still present, whether the powder looks as expected, and whether any documentation of transit conditions accompanied the package. Recording those observations at receiving is what makes a later stability question answerable.

Reconstituted material is a different regime

Once a lyophilized peptide is taken into solution its stability profile changes, because the water that the dry form excluded is now present. General practice treats reconstituted material as less stable than the sealed powder and factors in that repeated freezing and thawing is itself a stress. This note stops at that general statement deliberately; specific handling of solutions, including any quantities, is a protocol matter outside a storage overview. The chemistry of moving between the dry and dissolved states is covered separately in the sequence-science notes.

Freeze-thaw cycling as a cumulative stress

The reason repeated freezing and thawing draws particular attention is that its effect accumulates. Each cycle takes a material through the transitions where water reorganises around the peptide, and for sensitive sequences the cumulative exposure across many cycles can matter more than any single freeze. The general handling response, at the level a laboratory documents rather than prescribes, is to minimise the number of times a given portion of material is cycled. In practice that concern is one of the reasons single-use aliquoting is discussed in handling procedures, though the specifics of how a solution is divided and stored are a protocol question rather than a storage principle, and so sit outside this overview.

What belongs firmly inside a storage discussion is the observation that stability claims are always conditional on handling history. A material held continuously cold, dry, and dark has a very different expected trajectory from one that has been warmed, opened in humid air, or cycled repeatedly, even when both carry the same original documentation. This is precisely why the receiving and storage record is not clerical overhead but part of the evidence base: it is what lets a later anomaly be traced to a handling event rather than left as an unexplained result.

Recording what you did

Cold-chain handling is only as good as its record. A defensible inventory notes the storage temperature a material was held at, the condition it arrived in, and the dates of receipt and any transfers, so that the handling history can be reconstructed if a result later looks anomalous. That record-keeping discipline connects directly to the broader practice of documenting a research inventory, and related quality notes sit in the lab standards archive. The reasoning behind research-use-only handling is set out in the FAQ, and the wider technical collection is in Sequence Notes.

Common questions

Why are research peptides supplied as lyophilized powders?

Freeze-drying removes most water, and because many peptide degradation pathways depend on water, a dry solid is more stable than a solution at the same temperature. That is why reference peptides are shipped and stored as powders.

Why let a frozen vial warm up before opening?

Opening a cold vial in ambient air lets moisture condense onto the powder, reintroducing the water that freeze-drying removed. Allowing the sealed vial to reach room temperature first protects the dry state.

Does storage advice include how to reconstitute the material?

No. This note covers storage of the sealed powder only. Reconstitution, including any quantities, concentrations, or routes, is a protocol matter outside a general cold-chain handling overview.